(Approval lapsed) DRAXIMAGE sodium iodide I 131 solution, USP Diagnostic (Canada)
Section 19A approved medicine
(Approval lapsed) DRAXIMAGE sodium iodide I 131 solution, USP Diagnostic (Canada)
Section 19A approval holder
Australian Nuclear Science and Technology Organisation T/A ANSTO ABN 47 956 969 590
Phone
1800 251 572
Approved until
Status
Expired
Medicines in short supply/unavailable
AUSTRALIAN RADIOISOTOPES Sodium Iodide (I-131) 50 - 6000MBq Therapy Capsule vial - ARTG 22808
Sodium iodide(131I) 2000MBq/mL Therapy Solution oral liquid BP vial - ARTG 48267
Sodium iodide(131I) 200MBq/mL Therapy Solution oral liquid BP vial - ARTG 22807
Sodium iodide(131I) 2000MBq/mL Therapy Solution oral liquid BP vial - ARTG 48267
Sodium iodide(131I) 200MBq/mL Therapy Solution oral liquid BP vial - ARTG 22807
Indication(s)
Indicated in the treatment of hyperthyroidism, and the detection and ablation of residual functioning thyroid tissue in differentiated thyroid carcinoma.
Images
